1H-INDAZOLE, 3-IODO-6-METHYL-7-NITRO-
Names and Identifiers of 1H-INDAZOLE, 3-IODO-6-METHYL-7-NITRO-
CAS Number |
1000342-64-2 |
|---|---|
IUPAC Name |
3-iodanyl-6-methyl-7-nitro-2H-indazole |
Canonical SMILES |
CC1=C(C2=NNC(=C2C=C1)I)[N+](=O)[O-] |
Physical and chemical properties of 1H-INDAZOLE, 3-IODO-6-METHYL-7-NITRO-
Boiling Point |
453.9±40.0 °C at 760 mmHg |
|---|---|
Density |
2.1±0.1 g/cm3 |
Exact Mass |
302.950470 |
Flash Point |
228.3±27.3 °C |
Index of Refraction |
1.779 |
LogP |
3.24 |
Molecular Formula |
C8H6IN3O2 |
Molecular Weight |
303.057 |
PSA |
74.50000 |
Storage condition |
2-8°C(protect from light) |
Vapour Pressure |
0.0±1.1 mmHg at 25°C |
Applications of 1H-INDAZOLE, 3-IODO-6-METHYL-7-NITRO-
3-Iodo-6-methyl-7-nitro-1H-indazole has potential applications across various fields:
- Pharmaceuticals: Due to its biological activity, this compound may serve as a lead structure for drug development targeting specific diseases.
- Chemical Research: It can be used as a reagent in organic synthesis and material science for creating novel compounds.
- Biochemical Studies: Its interactions with biological molecules make it suitable for studies aimed at understanding enzyme mechanisms or receptor activities .
Interaction Studies of 1H-INDAZOLE, 3-IODO-6-METHYL-7-NITRO-
Interaction studies involving 3-Iodo-6-methyl-7-nitro-1H-indazole focus on its binding affinity to various biological targets. These studies often employ techniques such as:
- Molecular Docking: To predict how the compound interacts with specific proteins or enzymes.
- In vitro Assays: To evaluate its efficacy against microbial strains or cancer cell lines.
Preliminary findings suggest that this compound may inhibit certain cytochrome P450 enzymes, which are crucial for drug metabolism .
Biological Activity of 1H-INDAZOLE, 3-IODO-6-METHYL-7-NITRO-
Research indicates that compounds related to indazole structures exhibit a range of biological activities, including antimicrobial, anticancer, and anti-inflammatory properties. Specifically, 3-Iodo-6-methyl-7-nitro-1H-indazole has shown potential as an inhibitor of certain enzymes and receptors involved in disease processes. Its structural features may enhance its interaction with biological targets, leading to significant pharmacological effects .